A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects

NCT01915147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Chronic Pain

Interventions

DRUG: OXN PR followed by OxyPR tablets
DRUG: OxyPR followed by OXN PR tablets

Sponsor

Mundipharma Research GmbH & Co KG